会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 3. 发明授权
    • System for controlled release of biologically active compounds
    • 用于控制释放生物活性化合物的系统
    • US4933185A
    • 1990-06-12
    • US223887
    • 1988-07-11
    • Margaret A. WheatleyRobert S. LangerHerman N. Eisen
    • Margaret A. WheatleyRobert S. LangerHerman N. Eisen
    • A61K9/16A61K9/50A61K9/62
    • A61K9/1664A61K9/1652A61K9/5031Y10S514/885Y10S514/963Y10T428/2984Y10T428/2985
    • A controlled release system for delivery of a biologically-active substance. In one embodiment, there is a delayed release of a biologically-active substance. In a second embodiment, the delayed release is preceded by an initial release of biologically active substance. In other variations of the system, there are mulitple discrete releases over time or a continuous slow release combined with discrete releases. The delayed exposure is achieved through the design and construction of the system, specifically, formation of ionically-coated microcapsules around the biologically-active substance in conjunction with a microcapsule core-degrading enzyme. Release of active substance takes place in a burst at such a time as the core degrading enzyme has reduced the core to a molecular weight too low to support enough interaction with the cationic skin to maintain its integrity as a skin. In one example, microcapsules are formed of an ionically cross-linked polysaccharide, calcium alginate, which is further ionically coated with a poly-cationic skin of poly-L-lysine. The capsule coating serves a dual purpose: to control diffusion of the biologically-active substance and the core-degrading enzyme and as a substrate for the mechanism by which the biologically-active substance is released after a time delay.
    • 用于递送生物活性物质的控制释放系统。 在一个实施方案中,存在生物活性物质的延迟释放。 在第二个实施方案中,延迟释放之前是生物活性物质的初始释放。 在系统的其他变体中,随着时间的推移有多种离散的释放,或者连续的缓慢释放与离散的释放相结合。 延迟曝光是通过系统的设计和构建来实现的,具体地说,在微生物活性物质周围与微胶囊核心降解酶结合形成离子涂覆的微胶囊。 活性物质的释放在核心降解酶已经将核心降低到分子量太低以至于不能支持与阳离子皮肤的足够相互作用以维持其作为皮肤的完整性的时候发生。 在一个实例中,微胶囊由离子交联的多糖,藻酸钙形成,其进一步离子地涂覆有聚-L-赖氨酸的多阳离子皮肤。 胶囊涂层具有双重目的:控制生物活性物质和核心降解酶的扩散,并且作为延迟后释放生物活性物质的机制的底物。
    • 7. 发明授权
    • System for delayed and pulsed release of biologically active substances
    • 延迟和脉冲释放生物活性物质的系统
    • US4900556A
    • 1990-02-13
    • US161198
    • 1988-02-23
    • Margaret A. WheatleyRobert S. LangerHerman N. Eisen
    • Margaret A. WheatleyRobert S. LangerHerman N. Eisen
    • A61K9/127A61K9/16A61K9/50
    • A61K9/5031A61K9/127A61K9/1652Y10S514/963
    • A system for controlled release both in vivo and in vitro of entrapped substances, either at a constant rate over a period of time or in discrete pulses, is disclosed. Biologically active substances, such as drugs, hormones, enzymes, genetic material, antigens including viruses, vaccines, or inorganic material, such as dyes and nutrients, are entrapped in liposomes which are protected from the biological environment by encapsulation within semi-permeable microcapsules. Release of the entrapped substance into the surrounding environment is governed by the permeability of both the liposome and microcapsule walls to the substance. Permeability of the liposome is engineered by modifying the composition and method for making the liposomes, thereby producing liposomes which are sensitive to a specific stimuli such as temperature, pH, or light; or by including a phospholipase within some or all of the liposomes or the microcapsule; or by destabilizing the liposomes to break down over a period of time; or by any combination of these features.
    • 公开了一种在一段时间内或以离散脉冲以恒定速率在体内和体外捕获的物质的系统。 诸如药物,激素,酶,遗传物质,包括病毒的抗原,疫苗或无机材料(例如染料和营养素)的生物活性物质被包埋在通过包封在半透性微胶囊内而被保护免于生物环境的脂质体中。 被截留的物质向周围环境的释放由物质的脂质体和微胶囊壁的渗透性决定。 通过改变制备脂质体的组合物和方法来改进脂质体的渗透性,从而产生对特定刺激如温度,pH或光敏感的脂质体; 或者通过在一些或全部脂质体或微胶囊中包含磷脂酶; 或通过不稳定脂质体在一段时间内分解; 或通过这些特征的任意组合。
    • 9. 发明授权
    • System for delayed and pulsed release of biologically active substances
    • 延迟和脉冲释放生物活性物质的系统
    • US4921757A
    • 1990-05-01
    • US92554
    • 1987-09-03
    • Margaret A. WheatleyRobert S. LangerHerman N. Eisen
    • Margaret A. WheatleyRobert S. LangerHerman N. Eisen
    • A61K9/127A61K9/50A61K9/70
    • A61K9/703A61K9/127A61K9/5026A61K9/5031A61K9/7084Y10S436/829Y10S514/963Y10S514/965Y10T428/2984
    • A system for controlled release both in vivo and in vitro of entrapped substances, either at a constant rate over a period of time or in discrete pulses, is disclosed. Biologically active substances, such as drugs, hormones, enzymes, genetic material, antigens including viruses, vaccines, or inorganic material such as dyes and nutrients, are entrapped in liposomes which are protected from the biological environment by encapsulation within semi-permeable microcapsules or a permeable polymeric matrix. Release of the entrapped substance into the surrounding environment is governed by the permeability of both the liposome and surrounding matrix to the substance. Permeability of the liposome is engineered by modifying the composition and method for making the liposomes, thereby producing liposomes which are sensitive to a specific stimuli such as temperature, pH, or light; or by including a phospholipase within some or all of the liposomes or the surrounding matrix; or by destabilizing the liposome to break down over a period of time; or by any combination of these features.
    • 公开了一种在一段时间内或以离散脉冲以恒定速率在体内和体外捕获的物质的系统。 诸如药物,激素,酶,遗传物质,包括病毒的抗原,疫苗或诸如染料和营养素的无机材料的生物活性物质被包埋在通过包封在半渗透性微胶囊内的生物环境中保护的脂质体中 可渗透聚合物基体。 被截留的物质释放到周围环境中由脂质体和周围基质对物质的渗透性决定。 通过改变制备脂质体的组合物和方法来改进脂质体的渗透性,从而产生对特定刺激如温度,pH或光敏感的脂质体; 或通过在一些或全部脂质体或周围基质中包含磷脂酶; 或通过不稳定脂质体在一段时间内分解; 或通过这些特征的任意组合。
    • 10. 发明授权
    • Extracorporeal reactors containing immobilized species
    • 含有固定化物种的体外反应堆
    • US4863611A
    • 1989-09-05
    • US44245
    • 1987-04-30
    • Howard BernsteinMargaret A. WheatleyRobert S. Langer
    • Howard BernsteinMargaret A. WheatleyRobert S. Langer
    • A61M1/36B01D15/02B01J20/32
    • B01D15/02A61M1/3675B01J20/321B01J20/3212B01J20/3274
    • An apparatus for removing material from a biological solution consisting of a reactor chamber having an inlet and an outlet, a bioactive compound immobilized on particular supports within the reactor, means for retaining the particular supports within the reactor, means for recirculating the solution and the supports at a high flow rate within the reactor, and means for agitating or dispersing the recirculating solution-support mixture throughout the reactor chamber so as to prevent packing of the supports while not subjecting the solution to excessive or damaging forces.In the given example, an apparatus for the extracorporeal removal of heparin from blood is provided. Heparinase is immobilized on cross-linked agarose beads recirculated at a high flow rate through the reactor. Agitation of the blood-bead mixture sufficient to prevent packing of the beads within the reactor chamber is provided by means of a series of openings in the recirculation tube dispersing the mixture throughout the chamber.
    • 用于从由具有入口和出口的反应器室组成的生物溶液中去除材料的装置,固定在反应器内的特定载体上的生物活性化合物,用于将特定载体保持在反应器内的装置,用于将溶液和载体 反应器内的高流速,以及用于搅拌或分散循环溶液 - 载体混合物到整个反应器室的装置,以防止支撑物的包装,同时不使溶液经受过度或破坏的力。 在给出的实施例中,提供了用于从血液中体外去除肝素的装置。 肝素酶固定在通过反应器以高流速再循环的交联琼脂糖珠上。 借助于将混合物分散在整个室中的循环管中的一系列开口提供足以防止珠在反应器室内堆积的血珠混合物的搅动。